Covered recipient · General Payments record
KAREN E CARINI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,349.05
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.55 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $196.96 | 15 |
| Coherus Biosciences Inc. | $24.24 | 1 |
| Acerta Pharma LLC | $23.33 | 1 |
| Amgen Inc. | $22.52 | 1 |
| TerSera Therapeutics LLC | $16.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.41 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878723 | CMS |
| ABBVIE INC. | $14.95 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878725 | CMS |
| ABBVIE INC. | $0.84 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878727 | CMS |
| ABBVIE INC. | $1.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878729 | CMS |
| ABBVIE INC. | $14.03 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878731 | CMS |
| ABBVIE INC. | $9.38 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878733 | CMS |
| ABBVIE INC. | $18.90 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878735 | CMS |
| ABBVIE INC. | $12.88 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878737 | CMS |
| ABBVIE INC. | $1.33 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878739 | CMS |
| ABBVIE INC. | $12.06 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878741 | CMS |
| ABBVIE INC. | $15.50 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878743 | CMS |
| ABBVIE INC. | $15.51 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878745 | CMS |
| ABBVIE INC. | $34.58 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878747 | CMS |
| ABBVIE INC. | $16.19 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878749 | CMS |
| ABBVIE INC. | $20.25 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106878751 | CMS |
| Amgen Inc. | $22.52 | 05/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117217747 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.33 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105414580 | CMS |
| Coherus Biosciences Inc. | $24.24 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147277036 | CMS |
| TerSera Therapeutics LLC | $16.50 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144721909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.